Viewing SEC Facts Units
Company Name:
THERAVANCE BIOPHARMA, INC.
CIK:
1583107
Start Filing Date:
End Filing Date:
2023-05-01
ACCN:
0001558370-23-010149
Value:
$ 57,797,468
Value Error:
$ None
Created By:
Date Filed:
2023-05-18
FY:
2023
Fiscal Period:
Q1
Frame:
CY2023Q1I
Type:
dei
Form:
10-Q/A
Units:
shares